Hyperlipidemic LDL-R-–deficient mice transgenic for an OxPC-recognizing IgM fragment (scFv-E06) are protected against nonalcoholic fatty liver disease (NAFLD). The gene discussed is LDLR; the disease is metabolic dysfunction-associated steatotic liver disease.